| Literature DB >> 31167395 |
Mara Mandrioli1, Matilde Tura2, Stefano Scotti3, Tullia Gallina Toschi4.
Abstract
Cannabis has regained much attention as a result of updated legislation authorizing many different uses and can be classified on the basis of the content of tetrahydrocannabinol (THC), a psychotropic substance for which there are legal limitations in many countries. For this purpose, accurate qualitative and quantitative determination is essential. The relationship between THC and cannabidiol (CBD) is also significant as the latter substance is endowed with many specific and non-psychoactive proprieties. For these reasons, it becomes increasingly important and urgent to utilize fast, easy, validated, and harmonized procedures for determination of cannabinoids. The procedure described herein allows rapid determination of 10 cannabinoids from the inflorescences of Cannabis sativa L. by extraction with organic solvents. Separation and subsequent detection are by RP-HPLC-UV. Quantification is performed by an external standard method through the construction of calibration curves using pure standard chromatographic reference compounds. The main cannabinoids dosed (g/100 g) in actual samples were cannabidiolic acid (CBDA), CBD, and Δ9-THC (Sample L11 CBDA 0.88 ± 0.04, CBD 0.48 ± 0.02, Δ9-THC 0.06 ± 0.00; Sample L5 CBDA 0.93 ± 0.06, CBD 0.45 ± 0.03, Δ9-THC 0.06 ± 0.00). The present validated RP-HPLC-UV method allows determination of the main cannabinoids in Cannabis sativa L. inflorescences and appropriate legal classification as hemp or drug-type.Entities:
Keywords: Cannabis sativa L.; HPLC; cannabinoids; validation
Mesh:
Substances:
Year: 2019 PMID: 31167395 PMCID: PMC6600594 DOI: 10.3390/molecules24112113
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chromatographic trace of a standard cannabinoid mixture analyzed by RP-HPLC-UV equipped with reverse phase C18 column.
Figure 2Chromatographic trace of Cannabis sativa L. inflorescence extract analyzed by RP-HPLC-UV equipped with a reverse phase C18 column.
Validation parameters of RP-HPLC-UV method.
| Compound | R2 | 1 LOD (µg/mL) | 2 LOQ (µg/mL) | 3 LOD (µg/mL) | 4 LOQ (µg/mL) | Intraday (Repeatability) RSD | Interday (Repeatability) RSD | Reproducibility RSD | Recovery (%) |
|---|---|---|---|---|---|---|---|---|---|
| CBDA | 0.9999 | 0.34 | 1.05 | 0.11 | 0.37 | 5.65 | 5.05 | 0.09 | 96.06 |
| CBGA | 0.9999 | 0.32 | 0.98 | 0.12 | 0.40 | 4.71 | 4.34 | 2.13 | 93.90 |
| CBG | 0.9995 | 0.62 | 1.87 | 0.13 | 0.45 | 3.34 | 2.83 | 0.91 | 94.60 |
| CBD | 0.9995 | 0.63 | 1.91 | 0.17 | 0.58 | 4.89 | 4.44 | 0.70 | 84.92 |
| THCV | 0.9989 | 0.95 | 2.87 | 0.15 | 0.49 | - | - | N.d. * | N.d. * |
| CBN | 0.9999 | 0.28 | 0.84 | 0.06 | 0.21 | 2.59 | 2.95 | 0.81 | 97.08 |
| Δ9-THC | 0.9981 | 1.25 | 3.79 | 0.15 | 0.50 | 3.05 | 3.22 | 0.13 | 99.69 |
| Δ8-THC | 0.9987 | 1.02 | 3.10 | 0.17 | 0.56 | 3.81 | 3.64 | 0.74 | 100 |
| CBC | 0.9999 | 0.29 | 0.88 | 0.11 | 0.36 | 5.3 | 4.78 | 0.89 | 98.68 |
| THCA | 0.9998 | 0.43 | 1.29 | 0.11 | 0.37 | 5.55 | 5.01 | 1.91 | 95.27 |
1 Limit of detection (LOD) determined by the calibration curves (Instrumental LOD = (3.3 × σ)/m). 2 Limit of quantification (LOQ) determined by the calibration curves (Instrumental LOQ = (10 × σ)/m). 3 LOD determined by the signal-to-noise ratio (Instrumental LOD: S/N = 3). 4 LOQ determined by the signal-to-noise ratio (Instrumental LOQ: S/N = 10). * Not detectable.
Number of cannabinoids in hemp samples.
| Cannabinoids | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sample | CBDA | CBGA | CBG | CBD | THCV | CBN | Δ9-THC | Δ8-THC | CBC | THCA |
|
| 0.88 ± 0.04 | 0.02 ± 0.00 | 0.02 ± 0.00 | 0.48 ± 0.02 | N.d. * | 0.01 ± 0.00 | 0.06 ± 0.00 | 0.03 ± 0.00 | 0.03 ± 0.00 | 0.03 ± 0.00 |
|
| 0.93 ± 0.06 | 0.02 ± 0.00 | 0.02 ± 0.00 | 0.45 ± 0.03 | N.d. * | 0.01 ± 0.00 | 0.06 ± 0.00 | 0.03 ± 0.00 | 0.02 ± 0.00 | 0.04 ± 0.00 |
* Not detectable.